Insider: Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER - Travere Therapeutics, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 54,410 | 0 | 54,410 |
| Value | $1,343,927.00 | $0.00 | $1,343,927.00 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 02/11/2025 | DDS | 9,244 | Direct | COM | $25.00 | $231,100.00 | 54,410 |
| 02/11/2025 | DDS | 10,000 | Direct | COM | $25.00 | $250,000.00 | 63,654 |
| 02/11/2025 | DDS | 10,000 | Direct | COM | $25.00 | $250,000.00 | 63,654 |
| 02/11/2025 | DDS | 10,000 | Direct | COM | $25.00 | $250,000.00 | 63,654 |
| 02/11/2025 | DDS | 15,000 | Direct | COM | $25.00 | $375,000.00 | 63,654 |
| 02/03/2025 | DDS | 3,348 | Direct | COM | $20.12 | $67,361.76 | 63,654 |
| 01/22/2025 | DDS | 925 | Direct | COM | $18.94 | $17,520.24 | 54,002 |
| 12/26/2024 | DDS | 15,000 | Direct | COM | $17.22 | $258,277.50 | 54,927 |
| 11/25/2024 | DDS | 12,090 | Direct | COM | $18.30 | $221,257.88 | 54,927 |
| 02/01/2024 | DDS | 2,820 | Direct | COM | $8.53 | $24,057.98 | 52,017 |
| 01/23/2024 | DDS | 910 | Direct | COM | $9.07 | $8,252.24 | 41,337 |
| 05/11/2023 | DDS | 122 | Direct | COM | $16.12 | $1,966.64 | 42,247 |
| 05/10/2023 | DDS | 436 | Direct | COM | $16.59 | $7,233.24 | 42,369 |
| 02/02/2023 | DDS | 360 | Direct | COM | $22.42 | $8,071.20 | 42,805 |
| 02/01/2023 | DDS | 1,671 | Direct | COM | $21.75 | $36,347.59 | 43,165 |
| 01/25/2023 | DDS | 192 | Direct | COM | $21.63 | $4,152.96 | 34,836 |
| 01/24/2023 | DDS | 905 | Direct | COM | $21.90 | $19,823.48 | 35,028 |
| 09/13/2022 | DDS | 349 | Direct | COM | $28.00 | $9,772.00 | 35,933 |
| 05/11/2022 | DDS | 445 | Direct | COM | $21.92 | $9,755.96 | 35,733 |
| 05/10/2022 | DDS | 436 | Direct | COM | $21.51 | $9,378.36 | 36,178 |
| 01/31/2022 | DDS | 798 | Direct | COM | $26.51 | $21,151.71 | 36,614 |
| 01/24/2022 | DDS | 934 | Direct | COM | $24.58 | $22,954.64 | 28,662 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research